Edoardo Francini

Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC)

Edoardo Francini, Kathryn P. Gray, Wanling Xie et al. · The Prostate · 2018 · 198 citations · Full text

Medicine, Oncology, Urology +14

Tumor fraction in cell-free DNA as a biomarker in prostate cancer

Atish D. Choudhury, Lillian Werner, Edoardo Francini et al. · JCI Insight · 2018 · 146 citations · Full text

Medicine, Molecular Biology, Oncology +17

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database

Dorothea Wagner, Axel Grothey, Thierry André et al. · JNCI Journal of the National Cancer Institute · 2020 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids

Guido Francini, Roberto Petrioli, A Montagnani et al. · British Journal of Cancer · 2006 · 80 citations · Full text

Medicine, Endocrinology, Oncology +15

Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial)

Pierpaolo Correale, Pierosandro Tagliaferri, Antonella Fioravanti et al. · Clinical Cancer Research · 2008 · 76 citations · Full text

Medicine, Immunology, Oncology +17